⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8474751 | 0.80 | — | — | |
| SCHEMBL21942581 | 0.80 | — | — | |
| SCHEMBL23863495 | 0.80 | — | — | |
| SCHEMBL856620 | 0.78 | — | — | |
| SCHEMBL17525149 | 0.78 | — | — | |
| SCHEMBL14498531 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL57001 | 0.74 | — | — | |
| SCHEMBL14898445 | 0.72 | — | — | |
| SCHEMBL18632351 | 0.72 | — | — | |
| SCHEMBL726193 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3177611-B1 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | NUEVOLUTION AS (DK) | 2021-10-06 | — | — | EP | disclosed |
| EP-1572210-A1 | THE R-ISOMER OF BETA AMINO ACID COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES | Pharmacia Corporation (US) | 2005-09-14 | — | — | EP | disclosed |
| US-6906051-B2 | Lactone integrin antagonists | PHARMACIA CORPORATION (US) | 2005-06-14 | — | — | US | disclosed |
| US-20050020505-A1 | R-isomer of beta amino acid compounds as integrin receptor antagonists derivatives | PHARMACIA CORPORATION | 2005-01-27 | — | — | US | disclosed |
| WO-2004060376-A1 | THE R-ISOMER OF BETA AMINO ACID COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES | PHARMACIA CORPRATION (US) | 2004-07-22 | — | — | WO | disclosed |
| US-20040116472-A1 | Lactone integrin antagonists | PHARMACIA CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-6720327-B2 | ALPHA V BETA 5 (VITRONECTIN RECEPTOR) ANTAGONISTS FOR TREATMENT OF PROLIFERATIVE DISEASE SUCH A TUMOR METASTASIS, ANGIOGENESIS, RESTENOSIS | PHARMACIA CORPORATION | 2004-04-13 | — | — | US | disclosed |
| US-20040019206-A1 | Lactone integrin antagonists | RUMINISKI PETER (US) | 2004-01-29 | — | — | US | disclosed |
| EP-1320363-A4 | LACTONE INTEGRIN ANTAGONISTS | PHARMACIA CORP (US) | 2004-01-28 | — | — | EP | disclosed |
| EP-1320363-A1 | LACTONE INTEGRIN ANTAGONISTS | Pharmacia Corporation (US) | 2003-06-25 | — | — | EP | disclosed |
| US-20020045645-A1 | Lactone integrin antagonists | PHARMACIA CORPORATION | 2002-04-18 | — | — | US | disclosed |
| WO-2002026227-A1 | LACTONE INTEGRIN ANTAGONISTS | PHARMACIA CORPORATION (US) | 2002-04-04 | — | — | WO | disclosed |